Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-08T08:31:07.791Z Has data issue: false hasContentIssue false
  • English
  • Français

Osteoporosis

Published online by Cambridge University Press:  17 November 2008

SA Duursma ,
JA Raymakers ,
BAA Scheven  and
PAF Jansen
SA Duursma*
Affiliation:
University Hospital Utrecht, The Netherlands
JA Raymakers
Affiliation:
University Hospital Utrecht, The Netherlands
BAA Scheven
Affiliation:
University Hospital Utrecht, The Netherlands
PAF Jansen
Affiliation:
University Hospital Utrecht, The Netherlands
*
SA Duursma, Department of Geriatrics, University Hospital Utrecht, PO Box 85500, 3508 GA Utrecht, The Netherlands.
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Clinical geriatrics
Information
Reviews in Clinical Gerontology , Volume 3 , Issue 2 , May 1993 , pp. 135 - 146
Copyright
Copyright © Cambridge University Press 1993

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Albright, FA, Reifenstein, ED.The parathyroid glands and metabolic bone disease. Baltimore: Williams & Wilkins, 1948.Google Scholar
2Riggs, BL, Melton, LJ.Osteoporosis, etiology, diagnosis and management. New York: Raven Press, 1988.Google Scholar
3Riggs, BL, Melton, LJ.The prevention and therapy of osteoporosis. N Engl J Med 1992; 327: 620–27.Google ScholarPubMed
4Cooper, C, Atkinson, EJ, O'Fallon, WM, Melton, LJ.The incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res 1992; 7: 221–27.CrossRefGoogle ScholarPubMed
5Cooper, C, Shah, S, Hand, DJ, Compston, J, Davie, M.Screening for osteoporosis using individual risk factors. Osteoporosis Int 1991; 2: 48–53.CrossRefGoogle ScholarPubMed
6Cooper, C.Vertebral fractures. How large is the silent epidemic? Br Med J 1992; 304: 793–94.Google Scholar
7Resnick, NM, Greenspan, SL.‘Senile’ osteoporosis reconsidered. JAMA 1989; 261: 1025–29.CrossRefGoogle ScholarPubMed
8Van, Os C.Transcellular calcium transport in intestinal and renal epithelial cells. Biochem Biophys Acta 1987; 906: 195–22.Google Scholar
9Bronner, F. Calcium absorption. In: Johnson, LR ed. Physiology of the gastrointestinal tract, second edition. New York: Raven Press, 1987: 1419–34.Google Scholar
10Heersche, JNM. Bone cells and bone turnover; the basis for pathogenesis. In: Tarn, CS, Heersche, JNM, Murray, TM eds. Metabolic bone disease: cellular and tissue mechanism. Boca Raton: CRC Press, 1989: 1–19.Google Scholar
11Hodgson, SF.Corticosteroid-induced osteoporosis. Endocrinol Metab Clin North Am 1990; 19: 95–112.CrossRefGoogle ScholarPubMed
12Duursma, SA, Slootweg, MC, Bijlsma, JWJ. How does oestrogen prevent postmenopausal osteoporosis? In: Bergener, M, Ermini, M, Stāhelin, HB eds. Crossroads in aging. Academic Press, 1988: 169–80.Google Scholar
13Reginster, TY, Deroisy, R, Albert, A.Relationship between whole plasma calcitonin levels, calcitonin secretion capacity, and plasma levels of estron in healthy women and postmenopausal osteoporotics. J Clin Invest 1989; 83: 1073–77.CrossRefGoogle ScholarPubMed
14Tørring, O, Bucht, E, Sjöberg, HE.The influence of sex steroid hormones on plasma calcitonin response to the calcium clamp in normal subjects. J Bone Miner Res 1987; 2: 407–11.CrossRefGoogle Scholar
15Feyen, JHM, Raisz, LG.Prostaglandin production by calvaria from sham operated rats: effect of 17 '-estradiol in vivo. Endocrinology 1987; 121: 819–21.Google Scholar
16Duursma, SA, Jaszmann, LBJ, De Raadt, ME, Van Rhijn, HJM, Wit, JM, Raymakers, JA. Changes in insulin-like growth factor-I and growth hormone and prevention of bone loss during oestrogen replacement therapy. Growth Regulation 1992 (in press).Google Scholar
17McCarthy, TL, Centrella, M, Canalis, E.Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology 1989; 124: 301–309.CrossRefGoogle Scholar
18Scheven, BAA, Hamilton, NJ.Stimulation of macrophage growth and induction of multinucleated cell formation in rat bone marrow cultures by insulin-like growth factor. Biochem Biophys Res Commun 1992; 174: 647–53.CrossRefGoogle Scholar
19Slootweg, MC, Hermann-Erlee, MPM, Van der Meer, JM, Duursma, SA.Fetal mouse osteoblasts respond to physiological concentrations of growth hormone and produce insulin-like growth factors. Calcif Tissue Int 1987; 46 (suppl): OP11.Google Scholar
20Slootweg, MC, Otte, AP, Van Genesen, AP, Duursma, SA, Kuijer, W.Signal transduction of mouse osteoblast growth hormone receptor: independent of phosphoinositide breakdown and c-AMP. J Bone Miner Res 1989; 4 (suppl): S340.Google Scholar
21Scheven, BAA, Damen, CA, Hamilton, NJ, Verhaar, HJJ, Duursma, SA.Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osteoblast-like cells in vitro. Biochem Biol Res Commun 1992; 186: 54–60.Google Scholar
22Jilka, RL, Hangoc, G, Girasolr, G et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992; 257: 89–91.CrossRefGoogle ScholarPubMed
23Tobias, JH, Chambers, TJ.The effect of sex hormones on bone resorption by rat osteoclasts. Acta Endocrinol (Copenh) 1991; 124: 121–27.Google Scholar
24Mosekilde, L, Eriksen, EF, Charles, P.Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North 1990; 19: 35–64.CrossRefGoogle ScholarPubMed
25Parisien, M, Silverberg, SJ, Shane, E, Dempster, DW, Bilezikian, JP.Bone disease in primary hyperthyroidism. Endocrinol Metab Clin North Am 1990; 19: 19–34.CrossRefGoogle Scholar
26Baillie, SP, Davidson, CE, Johnson, FJ, Francis, RM.Pathogenesis of vertebral crush fractures in men. Age Ageing 1992; 21: 139–41.Google Scholar
27Jackson, JA, Riggs, MW, Spiekerman, AM.Testosterone deficiency as a risk factor for hip fractures in men: a case-control study. Am J Med Sci 1992; 304: 4–8.Google Scholar
28Rudman, D, Feller, AG, Cohn, L, Shetty, KR, Rudman, IW, Draper, MW.Effects of human growth hormone on body composition in elderly men. Horm Res 1991; 36: 73–81.CrossRefGoogle ScholarPubMed
29Duursma, SA, Raymakers, JA. Osteoporosis and exercise. In: Hermans, GPH, Mosterd, WL eds. Sports, medicine and health. Amsterdam: Elsevier, 1990: 119–28.Google Scholar
30Blumenthal, JA, Emery, CF, Madden, DJ et al. Effects of exercise training on bone density in older men and women. J Am Geriatr Soc 1991; 39: 1065–70.CrossRefGoogle Scholar
31McKenna, MJ.Differences in vitamin D status between countries in young adults and the elderly. Am J Med 1992; 93: 69–77.CrossRefGoogle ScholarPubMed
32McMurthy, CT, Young, SE, Downs, RW, Adler, RA.Mild vitamin D deficiency and secondary hyperparathyroidism in nursing home patients receiving adequate dietary vitamin D. J Am Geriatr Soc 1992; 40: 343–47.CrossRefGoogle Scholar
33Lips, P, Van Ginkel, FC, Jongen, MJ.Determinants of vitamin D status in patients with hip fracture and elderly control subjects. Am J Clin Nutr 1987; 46: 1005–10.CrossRefGoogle ScholarPubMed
34Zetterberg, C, Mannius, S, Melstrom, D, Rundgren, A, Astrand, K.Osteoporosis and back pain in the elderly. A controlled epidemiologic and radiographic study. Spine 1990; 15: 783–86.CrossRefGoogle ScholarPubMed
35Finsen, V.Osteoporosis and back pain among the elderly. Acta Med Scand 1988; 223: 443–49.Google Scholar
36Leidig, G, Minne, HW, Sauer, P, Wüster, C, Wüster, L, Lojen, M.A study of complaints and their relation to vertebral destruction in patients with osteoporosis. Bone Miner 1990; 8: 217–29.CrossRefGoogle ScholarPubMed
37Christiansen, C, Riis, BJ, Rodbro, P.Prediction of rapid bone loss in postmenopausal women. Lancet 1987; i: 1105–1108.CrossRefGoogle Scholar
38Melton, LJ, Kan, SH, Wahner, HW, O'Fallon, WM.Riggs, BL.Epidemiology of vertebral fractures in women. Am J Epidemiol 1989; 129: 1000–11.Google Scholar
39Ross, PD, Wasnich, RD, Vogel, JM.Detection of prefracture spinal osteoporosis using bone mineral absortiometry. J Bone Miner Res 1988; 3: 1–11.Google Scholar
40Eastell, R, Cedel, SL, Wahner, HW, Riggs, BL, Melton, LJ.Classification of vertebral fractures. J Bone Miner Res 1991; 6: 207–15.CrossRefGoogle ScholarPubMed
41Conference Report. Consensus development conference: prophylaxis and treatment of osteoporosis. Osteoporosis Int 1991; 1: 114–17.CrossRefGoogle Scholar
42Dequeker, J, Geusens, P.Treatment of established osteoporosis and rehabilitation: current practice and possibilities. Maturitas 1990; 12: 1–36.Google Scholar
43Kanis, JA, Passmore, R.Calcium supplementation of the diet: not justified by present evidence. Br Med J 1989; 298: 205–208.CrossRefGoogle ScholarPubMed
44Nordin, BEC, Heaney, RP.Calcium supplementation of the diet: justified by present evidence. Br Med J 1990; 300: 1056–60.Google Scholar
45Elders, PJM, Netelenbos, JC, Lips, P.Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. J Endocrinol Metab 1991; 73: 533–40.CrossRefGoogle ScholarPubMed
46Lindsay, R, Thome, JF. Estrogen treatment with established postmenopausal osteoporosis. Obstet Gynecol 1990; 76: 290–95.Google ScholarPubMed
47Lufkin, EG, Wahner, HW, O'Fallon, WM, Hodgson, WF, Kotowicz, MA, Lane, AW.Treatment of osteoporosis by transdermal estrogen administration. Ann Intern Med 1992; 117: 1–9.CrossRefGoogle Scholar
48Ott, SM.Estrogen therapy for osteoporosis. Even in the elderly. Ann Intern Med 1992; 117: 85–86.CrossRefGoogle ScholarPubMed
49Need, AG, Horowitz, M, Walker, CJ, Chatterton, BE, Chapman, IC, Nordin, BEC.Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis. Bone 1987; 10: 3–6.Google Scholar
50Hassager, C, Riis, BJ, Podenphant, J, Christiansen, C.Nandrolone decanoate treatment of postmenopausal osteoporosis for two years and effects of withdrawal. Maturitas 1989; 11: 305–17.CrossRefGoogle ScholarPubMed
51Johansen, JS, Hassager, C, Podenphant, J.Treatment of postmenopausal osteoporosis. Is anabolic steroid nandrolone decanoate a candidate? Bone Miner 1989; 6: 77–86.Google Scholar
52Lyritis, GP, Tsakalakos, N, Magiasis, B, Karachalios, B, Yiatzides, A, Tsekoura, M.Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double blind placebo controlled clinical study. Calcif Tissue Int 1991; 49: 369–72.Google Scholar
53Civitelli, R, Gonelli, S, Zacchei, F.Bone turn-over in postmenopausal osteoporosis: effect of calcitonin treatment. J Clin Invest 1988; 82: 1268–74.Google Scholar
54Reginster, JY, Dennis, D, Albert, A.1-year controlled randomization trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancel 1987; ii: 1481–83.CrossRefGoogle Scholar
55Reginster, JY.Effect of calcitonin on bone mass and fracture rate. Am J Med 1991; 91: 19–22.CrossRefGoogle Scholar
56Overgaard, K, Riis, BJ, Christiansen, C, Hansen, MA.Effect of calcitonin given intranasally on early postmenopausal bone loss. Br Med J 1989; 299: 477–79.CrossRefGoogle ScholarPubMed
57Ringe, JD, Welzel, D.Salmon calcitonin in the therapy of corticoid-induced osteoporosis. Eur J Pharmacol 1987; 33: 35–39.Google ScholarPubMed
58Storm, T, Thamsborg, G, Steiniche, T, Genant, HK, Sørensen, OH.Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990; 322: 1265–71.Google Scholar
59Watts, NB, Harris, ST, Genant, HK, Wasnich, RD, Miller, PD, Jackson, RD. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990; 323: 73–79.Google Scholar
60Reid, IR, King, AR, Alexander, CJ, Ibbertson, HK. Prevention of steroid-induced osteoporosis with (3 amino-1-hydroxypropylidene)-1, 1-bisphosphonate (APD). Lancet 1988; i: 143–46.CrossRefGoogle Scholar
61Lau, HW, Farley, JR, Baylink, DJ. Molecular mechanism of the mitogenic action of fluoride: inhibition of osteoblastic acid phosphatase-like phosphotyrosyl protein phosphatase activity. In: Christiansen, C, Johansen, JS, Riis, BJ eds. Osteoporosis 1987. Copenhagen: Osteopress ApS, 1987: 824–28.Google Scholar
62Kappelle, JW. Effects of 24,25 dihydroxycholecalciferol in healthy subjects and patients treated with fluoride for osteoporosis [Thesis]. Utrecht, 1991.Google Scholar
63Duursma, SA, Raymakers, JA, De Raadt, ME, Karsdorf, MJGH, Van Dijk, A, Glerum, J.Urinary fluoride excretion in responders and nonresponders after fluoride therapy in osteoporosis. J Bone Miner Res 1990; 5 (suppl 1): S43–47.Google Scholar
64Pak, CYC, Sakhaee, K, Zerwekh, JE, Parcel, C, Peterson, R, Johnson, K.Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone loss and inhibition of fractures. J Clin Endocrinol Metab 1990; 68: 150–59.Google Scholar
65Delmas, PD, Dupuis, J, Duboeuf, F, Chapuy, MC, Meunier, PJ.Treatment of vertebral osteoporosis with disodium monofluorophosphate: comparison with sodium fluoride. J Bone Miner Res 1990; 5 (suppl 1): S143–47.Google ScholarPubMed
66Riggs, BL, Hodgson, SF, O'Fallon, WF.Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990; 322: 802–809.CrossRefGoogle ScholarPubMed
67Kleerekoper, M, Peterson, EL, Nelson, DA.A randomized trial of sodium fluoride as a treatment postmenopausal osteoporosis. Osteoporosis Int 1991; 1: 155–61.Google Scholar
68Mamelle, N, Meunier, PJ, Netter, P.Fluoride and vertebral fractures. Lancet 1990; i: 336–43.Google Scholar
69Canalis, E, Centrella, M, Burch, W, McCarthy, TL.Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone culture. J Clin Invest 1989; 83: 60–65.CrossRefGoogle Scholar